HIF1A and COVID-19: Since acute tubular necrosis is one of the most common changes observed in patients with AKI triggered by COVID-19 (Sharma et al., 2020; Su et al., 2020; Stasi et al., 2021), the increase in HIF-1α may be protective against the nephrological damage caused by the disease.